Peer-reviewedCC BYCadernos de saude publica
Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.
- 1Universidade Federal da Paraíba, João Pessoa, Brasil.
- 2London School of Economics and Political Science, London, U.K.
Related
- Emerging Technologies in Granulation: Process Analytical Technologies and Modeling Approaches in Pharmaceutical Development and Manufacturing
- Flexible Printed RFID Tag Antennas for Scalable and Sustainable IoT: Design Physics, Manufacturing Technologies, and System-Level Validation
- Artificial Intelligence in Manufacturing Quality Assurance: Applications, Challenges, and Opportunities for Emerging Industrial Economies
- Additive manufacturing of ceramic materials for energy applications: Road map and opportunities
- Finite Element Simulation of Microwave Technologies for PowderBased Volumetric Additive Manufacturing Processes
BibTeX
@article{menezes2026trump,
title = {{Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.}},
author = {Henrique Zeferino de Menezes and Kenneth C Shadlen},
journal = {Cadernos de saude publica},
year = {2026},
month = oct,
doi = {10.1590/0102-311xen052426},
url = {https://europepmc.org/article/MED/42912037},
note = {CC BY},
}
RIS
TY - JOUR
TI - Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification.
AU - Henrique Zeferino de Menezes
AU - Kenneth C Shadlen
PY - 2026
DA - 2026/10/12
JO - Cadernos de saude publica
DO - 10.1590/0102-311xen052426
UR - https://europepmc.org/article/MED/42912037
SN - 0102-311X
SN - 1678-4464
ER -